Obese patients with T2D showed significantly reduced levels of OC in comparison with patients with lower degrees of glucose tolerance derangement. Our results also suggest that OC was the only bone marker independently related to the degree of glucose metabolism derangement in these patients.

The new compounds [Os3(CO)9(μ-CO){μ-η2-(Fc)CCSC⋮CSiMe3}] (1), [Os3(CO)10(μ-η1-SC⋮CSiMe3)(μ-η2-C⋮CFc)] (2), [Os3(CO)9(μ-η1-SC⋮CSiMe3)(μ3-η2-C⋮CFc)] (3), [Os3(CO)9(μ3-η2,η3,η3-{C5H5FeC5H3CCC(S)C(SiMe3)CHO}] (4), and [Os3(CO)9(μ3-S){μ3-η2-(Me3Si)CCC⋮CFc}] (5) were obtained from the reaction of FcC⋮CSC⋮CSiMe3 with the activated cluster Os3(CO)10(NCMe)2, as a result of S−C and C−H bond activation as well as C−C coupling reactions in the thioether. The crystal structures of all of them were determined by X-ray diffraction analysis.